Biosynex SA (EPA:ALBIO)
France · Delayed Price · Currency is EUR 0.8640
-0.0020 (-0.23%)
Mar 11, 2026, 5:35 PM CET
Biosynex Market Cap
Biosynex has a market cap or net worth of €16.2 million as of March 11, 2026. Its market cap has decreased by -41.78% in one year.
Market Cap
16.20M
Enterprise Value
68.48M
Revenue
97.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.86
Market Cap Chart
Since March 25, 2011, Biosynex's market cap has increased from 8.12M to 16.20M, an increase of 99.43%. That is a compound annual growth rate of 4.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 16.24M | 45.30% |
| Dec 31, 2025 | 11.17M | -39.63% |
| Dec 31, 2024 | 18.51M | -78.44% |
| Dec 29, 2023 | 85.85M | -39.13% |
| Dec 30, 2022 | 141.04M | -51.35% |
| Dec 31, 2021 | 289.89M | 91.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Median Technologies | 187.17M |
| Guerbet | 155.25M |
| Diagnostic Medical Systems | 32.63M |
| Implanet | 27.63M |
| Novacyt | 27.18M |
| Theraclion | 26.88M |
| Ikonisys | 24.08M |
| Mauna Kea Technologies | 16.85M |